Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections

NCT07704333 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

98

Enrollment

NIH

Sponsor class

Conditions

Aspergillos
Mucormye
Dimorphic
Other Molds
Non-Aspergillos
Non-Mucormycosis

Interventions

DRUG: [18F]-Fluorocellobiose ([18F]FCB)

Sponsor

National Institutes of Health Clinical Center (CC)